Bridge Point Advisory utilizes our deep China expertise, proprietary network of U.S healthcare and financial institutions to help Chinese pharmaceutical distributors to commercialize Western products. We aim to create long-term value for our clients from assisting with partner sourcing all the way to deal structuring and deal closing.